Cargando…
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
The impact of COVID-19 across health services, including treatment services for people who use drugs, is emerging but likely to have a high impact. Treatment services for people who use drugs provide essential treatment services including opiate agonist treatment and needle syringe programmes alongs...
Autores principales: | Dunlop, Adrian, Lokuge, Buddhima, Masters, Debbie, Sequeira, Marcia, Saul, Peter, Dunlop, Grace, Ryan, John, Hall, Michelle, Ezard, Nadine, Haber, Paul, Lintzeris, Nicholas, Maher, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201394/ https://www.ncbi.nlm.nih.gov/pubmed/32375887 http://dx.doi.org/10.1186/s12954-020-00370-7 |
Ejemplares similares
-
Opioid prescribing in Australia: too much and not enough
por: Dunlop, Adrian J, et al.
Publicado: (2021) -
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2016) -
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
por: Ezard, Nadine, et al.
Publicado: (2021) -
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018) -
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022)